Cargando…

Site-Specific Genome Engineering in Human Pluripotent Stem Cells

The possibility to generate patient-specific induced pluripotent stem cells (iPSCs) offers an unprecedented potential of applications in clinical therapy and medical research. Human iPSCs and their differentiated derivatives are tools for diseases modelling, drug discovery, safety pharmacology, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merkert, Sylvia, Martin, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964376/ https://www.ncbi.nlm.nih.gov/pubmed/27347935 http://dx.doi.org/10.3390/ijms17071000

Ejemplares similares

CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
por: Chaterji, Somali, et al.
Publicado: (2017)

An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders
por: Shum, Ian O., et al.
Publicado: (2023)

Efficient Designer Nuclease-Based Homologous Recombination Enables Direct PCR Screening for Footprintless Targeted Human Pluripotent Stem Cells
por: Merkert, Sylvia, et al.
Publicado: (2014)

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
por: Shankar, Keerthana, et al.
Publicado: (2020)

Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs
por: Ru, Renli, et al.
Publicado: (2013)

Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
por: Ge, Feixiang, et al.
Publicado: (2019)

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

Differentiation of Human Pluripotent Stem Cells Into Specific Neural Lineages
por: Chang, Chia-Yu, et al.
Publicado: (2021)

Disease-specific pluripotent stem cells
por: Kang, Hoon-Chul
Publicado: (2010)

Genome maintenance in pluripotent stem cells
por: Weissbein, Uri, et al.
Publicado: (2014)

Pluripotency of Stem Cells from Human Exfoliated Deciduous Teeth for Tissue Engineering
por: Rosa, Vinicius, et al.
Publicado: (2016)

Biomaterial Engineering for Controlling Pluripotent Stem Cell Fate
por: Bertucci, Taylor B., et al.
Publicado: (2018)

Germline specification from pluripotent stem cells
por: Yao, Chunmeng, et al.
Publicado: (2022)

Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
por: Zhao, Wei, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles
por: Zhao, Shudong, et al.
Publicado: (2023)

The pluripotent stem cell-specific transcript ESRG is dispensable for human pluripotency
por: Takahashi, Kazutoshi, et al.
Publicado: (2021)

Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells
por: Klawitter, Sabine, et al.
Publicado: (2016)

Design Principles for Pluripotent Stem Cell-Derived Organoid Engineering
por: Silva, Teresa P., et al.
Publicado: (2019)

Neural tissue engineering using embryonic and induced pluripotent stem cells
por: Willerth, Stephanie M
Publicado: (2011)

Genome editing of human pluripotent stem cells to generate human cellular disease models
por: Musunuru, Kiran
Publicado: (2013)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease
por: Rada-Iglesias, Alvaro, et al.
Publicado: (2011)

Author Correction: Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells
por: Klawitter, Sabine, et al.
Publicado: (2018)

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
por: Zhu, Huang, et al.
Publicado: (2019)

Patient-Specific Pluripotent Stem Cells in Neurological Diseases
por: Durnaoglu, Serpen, et al.
Publicado: (2011)

Cardiac differentiation of human pluripotent stem cells
por: Jiang, Junjie, et al.
Publicado: (2012)

Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering
por: Liu, Zhiqiang, et al.
Publicado: (2013)

Engineered Platforms for Maturing Pluripotent Stem Cell–Derived Liver Cells for Disease Modeling
por: Yuan, Yang, et al.
Publicado: (2023)

Induced Tissue-Specific Stem Cells and Epigenetic Memory in Induced Pluripotent Stem Cells
por: Noguchi, Hirofumi, et al.
Publicado: (2018)

Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2022)

Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells
por: Yamashita, Akihiro, et al.
Publicado: (2013)

Engineering human pluripotent stem cells into a functional skeletal muscle tissue
por: Rao, Lingjun, et al.
Publicado: (2018)

Engineering of targeted megabase-scale deletions in human induced pluripotent stem cells
por: Kotini, Andriana G., et al.
Publicado: (2020)

Engineering Human Pluripotent Stem Cell Lines to Evade Xenogeneic Transplantation Barriers
por: Pizzato, Hannah A., et al.
Publicado: (2023)

Standardization of human stem cell pluripotency using bioinformatics
por: Nestor, Michael W, et al.
Publicado: (2013)

Generation of universal and hypoimmunogenic human pluripotent stem cells
por: Ye, Qingsong, et al.
Publicado: (2020)

Human pluripotent stem cells: tools for regenerative medicine
por: Andrews, Peter W.
Publicado: (2021)

Pluripotent Stem Cells as a Model for Human Embryogenesis
por: Ávila-González, Daniela, et al.
Publicado: (2023)

Compromised Mitotic Fidelity in Human Pluripotent Stem Cells
por: Milagre, Inês, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mc5b2kj9k0776ibg3v2scs8a9a